FAS and posterior cortical atrophy: CD95 and the enzymes responsible for SSEA-4 synthesis displayed significantly elevated levels in post-docetaxel-based therapy patients and were correlated with poor survival probability, highlighting their potential as reliable biomarkers of docetaxel resistance and promising molecular targets for PCa therapy.